SECTOR : Biotech
ENTRY DATE : 2018
BUSINESS : Venture Capital
WEB : antabio.com

ANTABIO

Fighting drug resistant infections

Antabio is a Toulouse-based private biotech company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO.

PRESS RELEASE :

12/07/2018 • ANTABIO Completes €12.5m Series A
Read